Expression of the transcription factor Ets-1 is an independent prognostic marker for relapse-free survival in breast cancer.
about
The biology of the Ets1 proto-oncogenePhosphorylation of ETS1 by Src family kinases prevents its recognition by the COP1 tumor suppressorNovel role for PDEF in epithelial cell migration and invasionSTAT1 and Nmi are downstream targets of Ets-1 transcription factor in MCF-7 human breast cancer cellRegulation of p110delta PI 3-kinase gene expression.E2F5 status significantly improves malignancy diagnosis of epithelial ovarian cancerFBI-1 enhances ETS-1 signaling activity and promotes proliferation of human colorectal carcinoma cellsPTHrP gene expression in cancer: do all paths lead to Ets?Ets-1 regulates energy metabolism in cancer cells.Ets-1 is a transcriptional mediator of oncogenic nitric oxide signaling in estrogen receptor-negative breast cancer.Ets-1 global gene expression profile reveals associations with metabolism and oxidative stress in ovarian and breast cancersLinking signaling pathways to transcriptional programs in breast cancer.The ETS family of oncogenic transcription factors in solid tumours.Transcription factor Ets1 cooperates with estrogen receptor α to stimulate estradiol-dependent growth in breast cancer cells and tumors.Transcriptional silencing of ETS-1 abrogates epithelial-mesenchymal transition resulting in reduced motility of pancreatic cancer cellsEts-1 mediates upregulation of Mcl-1 downstream of XBP-1 in human melanoma cells upon ER stress.Estrogen receptor α enhances the transcriptional activity of ETS-1 and promotes the proliferation, migration and invasion of neuroblastoma cell in a ligand dependent manner.Breast cancer biomarkers and molecular medicine: part II.MiR-324-5p Suppresses Hepatocellular Carcinoma Cell Invasion by Counteracting ECM Degradation through Post-Transcriptionally Downregulating ETS1 and SP1.ETS transcription factors: possible targets for cancer therapy.Ets1 as a marker of malignant potential in gastric carcinoma.A positive role for PEA3 in HER2-mediated breast tumour progression.Overexpression of the Ets-1 transcription factor in human breast cancer.Ets2-dependent stromal regulation of mouse mammary tumorsStatins affect ETS1-overexpressing triple-negative breast cancer cells by restoring DUSP4 deficiencyCorrelated motions and interactions at the onset of the DNA-induced partial unfolding of Ets-1.Ets-1 regulates intracellular glutathione levels: key target for resistant ovarian cancer.Regulation of alphaB-crystallin gene expression by the transcription factor Ets1 in breast cancer.NMI promotes hepatocellular carcinoma progression via BDKRB2 and MAPK/ERK pathway.Mechanisms associated with mitochondrial-generated reactive oxygen species in cancer.Ets gene PEA3 cooperates with beta-catenin-Lef-1 and c-Jun in regulation of osteopontin transcription.Systematic identification of transcription factors associated with patient survival in cancers.Mapping of ESE-1 subdomains required to initiate mammary epithelial cell transformation via a cytoplasmic mechanism.Gene regulatory networking reveals the molecular cue to lysophosphatidic acid-induced metabolic adaptations in ovarian cancer cellsSilencing of ETS1 reverses adriamycin resistance in MCF-7/ADR cells via downregulation of MDR1.Evaluation of Combined Quantification of PCA3 and AMACR Gene Expression for Molecular Diagnosis of Prostate Cancer in Moroccan Patients by RT-qPCREts-1 regulates its target genes mainly by DNA methylation in human ovarian cancer.PIASy controls ubiquitination-dependent proteasomal degradation of Ets-1.Reciprocal regulation of RhoA and RhoC characterizes the EMT and identifies RhoC as a prognostic marker of colon carcinoma.Stromelysin-1 expression is activated in vivo by Ets-1 through palindromic head-to-head Ets binding sites present in the promoter.
P2860
Q21245748-49F40D65-3A9A-46E5-BE0C-74449C0FC5CAQ24301920-E0942339-DBD9-45FD-91A6-456C14827A76Q24633487-98A125ED-CDA9-4DE0-B3CC-9BDE4E038943Q28259950-EECFEC88-8A26-40B8-97C1-E09C692C0CBDQ33428537-00837D4D-BC85-443B-A974-A9FB50AF5E34Q33533979-D38885DF-8E23-4B71-BE0F-4BC62A316A6AQ33655198-5E9CFDFB-B215-47C3-AF0F-94F869442A12Q33705984-66B867BD-569A-4581-9D83-03C9FBEB933EQ33735978-F2AFAA67-82E6-4C4C-AC62-8D63DEF7241EQ33739233-01528D02-6DC0-4C04-8A42-BFC47ECE8324Q34258968-626CD97D-D56E-4A81-8C32-315824438B4FQ34439395-E7F82E59-9BA4-4C5E-B221-2F2C7E8D4972Q34555986-9B32062A-B07A-40A7-B6EB-F31E579D2074Q34851281-41464A51-92F5-4B38-93CE-4C7E1A4F0927Q35012520-6B16F9FA-E7C5-4E9A-9523-101BE9939E7DQ35185157-FE3D94EE-F2AC-4FD2-AC7A-6959C8147E30Q35677586-1EC8C0CE-7F42-4C14-9360-C2AA933275E1Q35680309-9A671414-8B78-4DDA-9C0D-0C4E8F72DC69Q35692510-D159F587-B2DD-4D96-A775-39F79CFEDEDFQ35857861-829698C3-8403-46FE-8938-D515149B661FQ36308623-A16F7950-40B2-41B6-98FC-FCB7A666F14DQ36612020-73C5983B-24F4-4D75-89AC-ACC2D5AFCDA7Q36695724-A945084A-68A7-4D2E-A843-E2E5AFAD25E2Q37062541-BF791437-2F97-44F5-A790-DA6E805FAD04Q37239999-DA47CBF1-8084-4233-9B52-26468DFD8DFFQ37279251-AF5A2DCD-9252-4384-AC92-74CEFFB4BE7DQ37348076-0B04F51F-5C43-447E-B406-D9D240C2C277Q37468205-1ED28FE9-7345-4C51-A4C0-1C92E8DD5D7FQ37707067-2DB2FD17-B5B3-47EA-AAA1-14A36220B291Q37731334-E705797D-6517-42AA-BB2B-D2463F36C1E3Q38344275-BCFFA3E2-8C45-43E8-9645-4C405A7A8941Q38354101-426BA0CF-0B29-4D63-8E5D-1B6C546B48A1Q38591719-2DE01306-0784-47EA-B852-5A62C65A0630Q38753397-8D20FC7B-61AC-4BCF-9F33-27877ED0F3AFQ38901160-FBD68B06-EBC7-4058-B5DA-EEE143483D06Q38997193-F7EA49ED-4527-46D1-AA7A-0350FCA9474AQ39064092-1863D783-11F9-4FD3-BA2E-DD0E7167CE14Q40141737-DEEC37E4-A8FC-44BB-A4E8-E1475CB3930DQ40277150-96BA126D-49DE-4F1C-BE1D-3A9A2B009C18Q40284696-E0E8160F-EF95-4EC0-A339-0170B6884930
P2860
Expression of the transcription factor Ets-1 is an independent prognostic marker for relapse-free survival in breast cancer.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Expression of the transcriptio ...... ree survival in breast cancer.
@en
Expression of the transcriptio ...... ree survival in breast cancer.
@nl
type
label
Expression of the transcriptio ...... ree survival in breast cancer.
@en
Expression of the transcriptio ...... ree survival in breast cancer.
@nl
prefLabel
Expression of the transcriptio ...... ree survival in breast cancer.
@en
Expression of the transcriptio ...... ree survival in breast cancer.
@nl
P2093
P356
P1433
P1476
Expression of the transcriptio ...... free survival in breast cancer
@en
P2093
Chris M G Thomas
Joop J Heuvel
Louk V A M Beex
Peggy Manders
Remko R Bosch
P2888
P304
P356
10.1038/SJ.ONC.1206040
P407
P577
2002-12-01T00:00:00Z